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ess: Pernilla.Glader@mSummary Chronic obstructive pulmonary disease (COPD) is a disease primarily
caused by cigarette smoking, which in turn has been shown to affect the
susceptibility to and progression of airway infections. The question addressed in
this study was how components from cigarette smoke could affect the defence
mechanisms of T-cells and epithelial cells, and thereby contribute to the
development of the COPD pathology. T-cells and monocytes were isolated from
buffycoats from healthy donors and T-cell responses studied in response to cigarette
smoke extract (CSE). Activation level (CD25 expression), proliferation (BrdU
incorporation) and intracellular expression of the cytotoxic markers granzyme-b
and TIA-1 were determined using flowcytometry. Normal human bronchial epithelial
cells were obtained from Cambrex and differentiated in air–liquid interface
cultures. After exposure to CSE barrier function (trans-epithelial electric resistance,
TEER), MUC5AC and interleukin-8 production were measured. T-cell activation,
proliferation and expression of the cytotoxic proteins granzyme-b and TIA-1 were
significantly reduced in response to 0.5–1% of CSE. The epithelial cells were more
resistant to CSE and responded at doses 20 times higher than T-cells. The expression
of interleukin-8 and MUC5AC was significantly increased after exposure to 15% and
30% CSE and TEER was largely unaffected at 30% CSE but clearly reduced at 40% CSE.
This study shows that mechanisms, in both T-cells and airway epithelial cells,
involved in the defence against infectious agents are modulated by CSE.
& 2005 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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In chronic obstructive pulmonary disease (COPD)
and chronic bronchitis, two smoke related diseases,
exacerbations are often triggered by respiratory
infections.1,2 In addition, these patients often show
colonization by bacteria in their lower respiratory
tract, an area that is normally sterile.1,3–5 This
bacterial colonization has been shown to persist
between exacerbations in the form of bio films or
even intracellular within the epithelial cells.6,7 It
has been shown that also asymptomatic smokers
suffer from respiratory infections more frequently
than non-smokers8 and studies on mice have shown
that the recovery from infections and the clearance
of virus and bacteria is impaired in response to
nicotine.9 This raises questions about whether
cigarette smoke has the ability to alter defence
mechanisms of the lung.
The defence against microbial and viral infections
in the respiratory tract is provided by a number of
different mechanisms. In the central airways the
epithelial lining is ciliated and covered with a
protective mucus layer able to transport particles
and microorganisms away from the central airways
by mucociliary clearance. This epithelial barrier
constitutes the first line of defence. Interspersed
between the epithelial cells, mucosal T-cells are
located as a specific defence against infectious
agents that are penetrating the mucosal barrier.
Further into the tissue, in the lamina propria,
macrophages, neutrophils and T-cells provide both
innate and adaptive immune responses to help clear
infections. In the lower respiratory tract, alveolar
macrophages are the key cells to keep the environ-
ment sterile with the help from, among others, T-
cells.10 Together these cells constitute the normal
defence of the lung, and have been shown to differ
in number and/or appearance in smoke related
diseases. Studies on bronchoalveolar lavage and
biopsies from smokers with chronic bronchitis or
COPD have revealed an increased number of CD8+ T-
cells in the lungs of smokers as compared to non-
smokers.11–13 Immunohistochemical studies of the
bronchial epithelium in COPD patients have re-
vealed a hypersecretory phenotype, with increased
production of airway mucins as well as goblet cell
hyperplasia. In more distal areas of the bronchial
tree, where mucin production is not normally seen,
goblet cell metaplasia has been demonstrated.14 In
addition, increased levels of proinflammatory cyto-
kines like interleukin-8 (IL-8), have been demon-
strated in sputum and bronchoalveolar lavage fluid
of COPD patients and probably accounts for the
large influx of neutrophils seen in the lungs of these
patients.10In the present study, T-cells and epithelial cells
were investigated with the hypothesis that both T-
cell and epithelial functions, involved in the
defence against infectious agents, could be altered
by the exposure to cigarette smoke components.
Both cell types were stimulated in vitro with an
aqueous cigarette smoke extract (CSE). Prolifera-
tion, activation and cytotoxic potential of the T-
cells as well as barrier integrity, MUC5AC and IL-8
production of airway epithelial cells grown in
air–liquid interface (ALI) cultures were studied.
Materials and methods
Cigarette smoke extract preparation
CSE was prepared in a way similar to what have been
published previously.15,16 Smoke from two filterless
Kentucky research cigarettes, 1R4F containing 11mg
tar and 0.8mg nicotine, was bubbled through 50ml
of cell culture medium (for T-cells RPMI-1640 and for
epithelial cells BEBM further described below) at a
speed of 5min per cigarette. The CSE was filtered
through a 0.2mm sterile filter (Corning, New York,
USA) before addition to cell cultures. The CSE was
used within 20min of preparation to avoid break-
down of substances in the extract and evaporation
of volatile components.
T-cell and monocyte preparation
Peripheral blood mononuclear cells (PBMCs), were
isolated from buffycoats from healthy blood donors
(Blood Centre, Lund University Hospital) by gradient
centrifugation on Ficoll-Paque (Amersham Pharmacia
Biotech, Sweden) according to the manufacturer’s
recommendations. Total CD3+ T-cell populations,
CD8+ T-cells and monocytes were extracted from
PBMCs by positive selection on MACS beads directed
against CD3, CD8 and CD14, respectively, using an
Automacs system according to the manufactures
instructions (Miltenyi biotec, Germany). The purity
of the cells was checked by flowcytometry analysis
for CD3, CD8, CD14 and CD16 using a FACS Calibur
instrument from Becton Dickinson and the Cellquest
Pro analysis software. The median values for purity
of cell populations extracted from PBMCs using MACS
beads were for CD3+ T-cells 97.5% (range: 90–98%)
CD8+ T-cells 98% (range: 97–98%) and CD14+ cells 90%
(range: 89–93%).
Culturing of T-cells and stimulation with CSE
Two types of T-cell cultures were set up; co-
cultures containing CD8+ T-cells and monocytes,
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CD3+ T-cells. All cultures were preformed in 24 well
plates coated with anti-CD3 and supplemented with
5 mg/ml of soluable anti-CD28 (BD Pharmingen, San
Diego, USA). Each well contained a total of one
million cells, in co-cultures 0.5 millions of CD8+ T-
cells and 0.5 millions of monocytes and in mono-
cultures one million CD3+ T-cells. Cells were
cultured in RPMI 1640 with glutamax-1 (a more
stable glutamine derivate) and 25mM HEPES
(Invitrogen/Gibco, Paisley, UK) supplemented with
10% foetal bovine serum and 1% penicillin–strepto-
mycin (Invitrogen/Gibco, Paisley, UK). CSE was
added to the cultures at the time of the seeding
in doses 0–1%. Incubation was performed at 5% CO2,
95% humidity in a tissue culture incubator.BrdU incorporation and Flowcytometry
On day 3 cultures for proliferation measurements
were pulsed with 1mM bromodeoxyuridine, BrdU
(BD Pharmingen, San Diego, USA) and incubated for
2 h before harvest. Cells in mono-cultures were
stained with antibodies against CD4 and CD8
(DAKO, Glostrup, Denmark) in order to monitor
changes in the individual cell populations, and cells
in the co-cultures were stained with antibodies
against CD8 before they were all fixed, permeabi-
lized and DNAse treated. The cells were then
stained for incorporated BrdU, using a monoclonal
BrdU antibody and a matched isotype control (BD
Pharmingen, San Diego, USA), and analysed on a
FACS Calibur. Cultures not used for proliferation
measurements were stained with antibodies
against CD25, CD4 and CD8 (DAKO, Glostrup,
Denmark) on the surface and granzyme-b (Serotec,
Oxford, UK) and TIA-1 (Immunotech, Marseille,
France) intracellulary after permeabilization with
Leucoperm (Serotec, Oxford UK). Matched isotype
controls (DAKO, Glostrup, Denmark) were used to
assure specificity of the positive antibody staining.
In initial experiments T-cell viability and live gate
settings in the flowcytometry analysis was evalu-
ated using FITC labeled Annexin V staining (Alexis
Corporation, Lausen, Switzerland). All FACS analy-
sis was performed on a FACS Calibur instrument (BD
Biosciences) using the Cellquest Pro software.Epithelial cell culture
Primary normal human bronchial epithelial cells
(NHBE) (donor NHBE 4892) were commercially
obtained from Cambrex (East Rutherford, NJ,
USA) at passage one. The cells were cultured in
Bronchial Epithelial Growth Medium (BEGM) con-sisting of Bronchial Epithelial Basal Medium (BEBM)
and all supplements, except antibiotics, according
to the vendor’s recommendations (Cambrex, East
Rutherford, NJ, USA). Cells were expanded in T75
flasks and frozen in aliquots at passage two. The
cells were differentiated in an ALI culture system
following the protocol of Gray et al.17 Briefly, the
cells were seeded on Vitrogen coated 12 well
Transwell clear insert plates (Corning, Acron, MA,
USA) at a density of 40,000 c/cm2 in 1.5ml BEGM
basolaterally and 0.5ml BEGM apically. Until reach-
ing confluency (typically at day 4) cells were
maintained in BEGM. The ALI was established by
removing the apical medium and replacing the
basolateral medium with ALI medium made up from
Dulbecco’s Modified Eagle’s Medium (DMEM) (Invi-
trogen/Gibco, Paisely, UK) and BEBM in a ratio 1:1,
supplemented with 0.4% bovine pituitary extract,
5 mg/ml insulin, 75 ng/ml hydrocortisone, 10 mg/ml
transferrin, 6.5 ng/ml T3, 0.5 mg/ml epinephrine,
0.5 ng/ml epidermal growth factor, 15 ng/ml reti-
noic acid and 1.5 mg/ml BSA (final concentrations).
The basolateral medium was changed daily during
weekdays. Excess mucus was removed by rinsing
the apical surface of the cells with 37 1C DMEM.
Following approximately 14 days in ALI culture
ciliated cells appeared. Cells were cultured for up
to 10 weeks and used for experiments. For
histological evaluation cultures were fixed in 4%
paraformaldehyde and embedded into paraffin.
Sections were stained with haematoxylin following
standard protocols.
CSE exposure to epithelial cells
ALI cultures (age of culture indicated within each
experiment) were starved for 24 h in BEBM medium
containing 1% insulin/transferrin/selenin (ITS) solu-
tion (Sigma-Aldrich, UK) and 0.1% BSA prior to the
experiments. Cells were apically rinsed to remove
excess mucus and apically exposed to indicate
concentrations of CSE in 300 ml BEBM for 30 h.
Assessment of barrier function in epithelial
cells
Development of trans-epithelial electrical resis-
tance (TEER) was monitored using chopstick
electrodes (Millipore, Billerica, MA, USA) as a
measurement of tight junctional barrier formation.
BEBM (300 ml) were applied to the apical com-
partment and TEER was measured in at least
two different locations of the culture. Only
cultures with a TEER value of X800O cm2 were
used in the CSE exposure experiments. ALI cultures
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CSE as described above and changes in TEER were
measured.
Determination of epithelial IL-8 release
ALI cultures differentiated for 10–12 weeks were
exposed to 15% and 30% of CSE as described above.
Initial experiments had shown that lower concen-
trations, 5–10%, had no substantial effect on
release of IL-8 (data not shown). The concentration
of basolaterally released IL-8 after CSE stimulation
was determined using a commercial IL-8 ELISA
according to the vendor’s recommendations (R&D
Systems, Minneapolis, MN, USA) and analysed using
a Spectramax plus spectrophotometer (Molecular
devices, Sunnyvale, CA, USA).
Determination of MUC5AC secretion
Apical secretion of MUC5AC was assessed using a
modification of the ELISA protocol of Takeyama et
al.18 Briefly the apical surface of cultures was
washed with 500 ml 37 1C DMEM and cells stimulated
with 15–30% of CSE as described above. After 30 h
of CSE stimulation the apical medium was col-
lected, centrifuged (1600 rpm/10min/4 1C) and
stored at 80 1C until analysis. For MUC5AC ELISA
70 ml of apical sample was mixed with 30 ml 0.05M
carbonate buffer and dried down on a RIA plate1101
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Figure 1 Live gating in flowcytometry analysis. The live c
negative population. The scatter plots show forward and side
is the characteristic Annexin-V positive cell population. The h
gate.(Corning, Acron, MA, USA) overnight at 37 1C.
MUC5AC protein was detected using the monoclo-
nal antibody 45M1 (Labvision, Freemont, CA, USA)
and an HRP-coupled goat-anti-mouse IgG secondary
antibody (Sigma, St. Louis, MO, USA) using colori-
metric detection. Plates were analysed using a
Spectramax plus photometer (Molecular devices,
Sunnyvale, CA, USA).
Statistics
Data were analysed using Wilcoxon Mann–Whitney
U-test using the Astute package for Excel (DDU
software, Leeds, UK). Differences between groups
were considered significant at Pp0:05.Results
T-cell viability
T-cell viability in response to CSE was assessed as
percent of cells in a live gate of the flowcytometry
analysis. The live gate was in initial experiments
defined as an Annexin-V negative population as
shown in Fig. 1. The viability of the T-cells exposed
to 0.1% and 0.5% CSE did not significantly differ
from that of cells grown in the absence of CSE. In
cells exposed to 1% CSE the viability was lower than
in unstimulated cells (Po0:05) 69% (range: 45–72%)10410302
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Figure 2 T-cell CD25 expression in response to CSE. CSE significantly reduced the expression of CD25 on T-cells grown
both in the absence and presence of monocytes. In both groups there was a significant reduction in CD25 expression at a
CSE concentration of 0.5% or more (Po0:05). Bars designating the median values.
P. Glader et al.822and 76% (range: 72–85%), respectively, in co-
cultures and 67% (range: 57–81%) and 84% (range:
83–90%), respectively, in mono-cultures. Only cells
in the live gate were used in the flowcytometry
analysis of activation, proliferation and cytotoxic
markers.T-cell activation and proliferation
The first experiments addressed the potential
effects of CSE on the most basic T-cell functions
such as general activation through the CD3/TcR
complex resulting in upregulation of the high
affinity IL-2 receptor (CD25) and proliferation. As
expected, T-cells grown in the presence of mono-
cytes had a statistically significant higher expres-
sion of CD25 compared to T-cells grown in the
absence of monocytes (Fig. 2). Addition of CSE
resulted in a significant reduction (Po0:05) in both
the degree of activation (CD25 expression) and
proliferation (BrdU incorporation) of the T-cells.
Addition of 0.5% CSE was enough to induce a
significant reduction in T-cell activation both in the
presence and absence of monocytes. The prolifera-
tion was significantly reduced by adding 0.5% CSE to
T-cells stimulated in the absence of monocytes and
by 1% CSE for T-cells in cocultures with monocytes
(Po0:05) (Fig. 3).T-cell cytotoxicity
Next set of experiments was designed to address
effects of CSE on the cytotoxic potential of the
T-cells. The expression of the two cytotoxicity
markers granzyme-b and TIA-1 was significantlyreduced in response to CSE. A significant reduc-
tion of granzyme-b was detected at 0.5% of CSE
in both mono-cultures (Po0:05) and co-cultures
(Po0:05) (Fig. 4). TIA-1 was significantly reduced in
CD4+ cells in mono-cultures at 0.5% of CSE
(Po0:05), while for CD8+ T-cells in the same
cultures the reduction of TIA-1 was not statistically
significant. In CD8+ T-cells grown in the pre-
sence of monocytes, however, there was a sig-
nificant decrease in TIA-1 at 0.5% of CSE (Po0:05)
(Fig. 5).Epithelial cell differentiation
ALI culturing of primary human epithelial cells
induced differentiation into basal, ciliated and
secretory (goblet) cells (Fig. 6). The morphological
differentiation was accompanied by the develop-
ment of a substantial TEER from day 13 in ALI
culture and peaked at 1665O cm2 around day 30.Epithelial responses to CSE exposure
Exposure of differentiated ALI cultures (cultured 21
days in ALI) to CSE concentrations up to 30% for 30 h
evoked no clear changes in TEER. However, 40% of
CSE resulted in a drastic reduction of the resistance
(Fig. 7). ALI cultures (cultured 10–12 weeks in ALI)
exposed to 15% and 30% of CSE responded with a
significant and dose dependent increase in baso-
lateral IL-8 release with median values of 159% and
238% of control, respectively (Po0:05) (Fig. 8).
Similarly, the apical MUC5AC secretion was sig-
nificantly increased in response to 15% and 30% of
CSE with median values of 190% and 246% of
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Figures 4 and 5 T-cell expression of cytotoxic markers in response to CSE. The cytotoxicity markers TIA-1 and
granzyme-b were both negatively affected by CSE. The granzyme-b expression was significantly reduced in both the
CD4+ and the CD8+ T-cells in the T-cell mono-cultures at a CSE concentration of 0.5% or more (Po0:05) (Fig. 4 (top))
while the TIA-1 expression in the same cells was significantly reduced in the CD4+ cells, at a CSE concentration of 0.5%
or more (Po0:05), but not in the CD8+ cells (Fig. 5 (bottom)). However, grown in the presence of monocytes the
expression of TIA-1 in CD8+ T-cells was significantly reduced at a CSE concentration of 0.5% or more (Po0:05) (Fig. 5), as
was the granzyme-b expression (Po0:05) (Fig. 4). Bars designating the median values.
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Figure 3 T-cell proliferation in response to CSE. The proliferation of T-cells, measured as incorporation of BrdU, was
significantly reduced in the presence of CSE. A significant reduction in proliferation was found at a CSE concentration of
0.5% or more for T-cells grown in the absence of monocytes (Po0:05) and at 1% for T-cells grown in the presence of
monocytes (Po0:05). Bars designating the median values.
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Figure 6 Epithelial cell layer appearance. In haematox-
ylin stained paraffin section of human epithelial cells
differentiated in ALI culture for 30 days, the cells showed
a clearly differentiated phenotype.
Figure 7 Effect of trans-epithelial electric resistance in
response to CSE. ALI cultures differentiated for 21 days
were exposed to CSE and TEER was measured in response
to different doses of CSE. Data points represent the mean
of 2–3 measurements of TEER in individual cultures. Bars
designating the median values.
Figures 8 and 9 Epithelial expression of IL-8 and MUC5AC
in response to CSE. Differentiated ALI cultures (10–12
weeks in ALI culture) were exposed to CSE and
basolateral concentrations of IL-8 and apical concentra-
tions of MUC5AC were measured. The IL-8 expression,
expressed as % change relative to control, was signifi-
cantly increased in response to both 15% and 30% of CSE
(Po0:05). Data points represent data from individual
cultures in three independent experiments (Fig. 8 (top)).
Apical secretion of MUC5AC in ALI cultures, expressed as
% change of control was also significantly increased in
response to both 15% and 30% of CSE (Po0:05). Data
points represent results from individual cultures in two
independent experiments (Fig. 9 (bottom)).
P. Glader et al.824control, respectively (Po0:05) (Fig. 9). At CSE
concentrations up to 30% ciliary beat remained
visible and no dead cells or disruption of the cell
layer were visible (data not shown). No IL-8 or
MUC5AC measurements were made in cultures
exposed to 40% CSE due to the clear cytotoxic
effects on the cells that was recorded as outlined
above.Discussion
A number of different pathological changes con-
tribute to the development of COPD. Proteolytic
tissue degradation possibly due to an imbalance in
the protease/anti-protease balance, may result in
emphysematous changes of the peripheral lungtissue, and a decline in lung function. In other cases
the obstruction seem more related to severe
bronchitis and bronchiolitis accompanied by occlu-
sion of small airways due to mucus plugging and
tissue remodelling, and in many cases combinations
of these events contribute to the disease progres-
sion.19 A third factor, possibly contributing to
progression of the disease, is reoccurring exacer-
bations, often triggered by airway infections.1,2,20
The present study focused on possible effects of
components in cigarette smoke on the defence
mechanisms against airway infections in T-cells and
epithelial cells.
Since T-cells from human airways are hard to
extract in numbers sufficient for functional analy-
sis, the T-cell responses to CSE in the present study
were studied using cells from peripheral blood. The
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CSE. Already at very low doses (0.5–1%) T-cells
responded with a reduction in CD25 expression,
proliferation and production of cytotoxic granule
proteins granzyme-b and TIA-1. This was seen in
both CD4+ and CD8+ T-cells even when the cells
were fully stimulated, as shown in co-culture
experiments with CD8+ T-cells and monocytes.
These results indicate that T-cells are very suscep-
tible to cigarette smoke in a way that could impair
their cytotoxic capacity to fight infections.
The epithelial cells, here represented by normal
bronchial epithelial cells grown in ALI, were much
more resistant to the CSE and responded with an
increased production of both MUC5AC and IL-8 at
doses up to 30% CSE. Not until 40% CSE was added
to the cells did the trans-epithelial resistance drop,
reflecting a breakdown of the epithelial integrity.
The epithelial cells hence show a strong resistance
to cigarette smoke and also respond in a way that
could affect their defence mechanisms. The in-
creased mucous-layer provides good protection
against particulate irritants, but also a suitable
milieu for colonization with bacteria which could
promote infections.21 The increased production of
the neutrophil chemo-attractant IL-8, contributes
to an increased innate host defence against
bacterial and viral infections, but much like the
mucus production, an increased number of neutro-
phils in the submucosa could also promote epithe-
lial cell-damage through release of proteases and
reactive oxygen species by these neutrophils,
thereby increasing susceptibility to the same
infections.22
To understand the reasons for the large differ-
ences seen between T-cell and epithelial cell
responses further analysis on active components
in CSE responsible for these effects has to be made.
Studies on T-cell proliferation in response to
components in cigarette smoke have shown results
similar to the present study. Geiselhart et al.
studied T-cell proliferation in response to tar
components and found that p-benzoquinone and
hydroquinone affected IL-2 dependent activation
and proliferation respectively in a negative
way.23,24 In another study by Geng et al.,25 rats
were exposed to nicotine via mini osmotic pumps
and T-cell proliferation was shown to be negatively
affected by nicotine at doses similar to those of
cigarette smokers. They also showed that TCR-
induced T-cell activation was decreased after
nicotine exposure. In two different studies where
epithelial cells were exposed to mainstream cigar-
ette smoke26 and acreolin,27 respectively, break-
down of the epithelium, shown as decline in TEER
and increase in passive transport of 14C-mannitol,was reported, indicating that volatile components
of the cigarette smoke could influence the epithe-
lial responses.
The culture conditions as well as different
compositions and concentrations of CSE used in in
vitro studies will of course influence the results. To
the authors knowledge only one study, made by
Andersson et al., has been published on T-cell
responses to CSE so far.15 In that study peripheral
blood T-cells were grown in culture conditions
similar to the ones in the present study, with the
exception of CSE stimulation performed during 20 h
instead of 72 h as done in the present study. The
readouts in the study by Andersson et al. were
different from the ones in the present study making
the data on CD25 expression, proliferation and
expression of granzyme-b and TIA-1 presented here
the first of their kind. With respect to epithelial
cells, these cells are reported to be more suscep-
tible to CSE when studied in submersed cultures
than are cells in ALI cultures28 (Mo¨ller, unpublished
observations). The production of MUC5AC and IL-8
in ALI cultures in response to CSE presented in this
study has to the authors knowledge not been
published before. These data support studies made
on the human epithelial cell line NCI-H292, which
showed similar results with increased MUC5AC
production in dose response to CSE29,30 and studies
made on cell lines and undifferentiated normal
bronchial epithelial cells which showed increased
IL-8 production in response to CSE.28,31
In the present study, T-cells and epithelial cells
were exposed to CSE prepared in the same way
making it easier to compare the results from the
different cell types. This is otherwise a problem
when comparing in vitro studies on cigarette smoke
exposure. The use of different definitions of CSE
dosage makes it hard to compare results from
different studies as some groups define doses as %
CSE16,32,33 others as cigarettes per millilitre34 and
yet others based on absorbance.35,36 Also, other
factors like the choice and number of cigarettes,
volume of medium and combustion rate may
influence the composition and effects of CSE and
make comparisons hard. Standardization of cigar-
ettes and smoke extraction protocols would be
useful tools for future studies.
Even though CSE stimulation is an in vitro based
system that should be interpreted with caution,
some clinical aspects could be discussed from the
study presented here. The CSE effect on T-cell
CD25 expression and proliferation was not surpris-
ing since many articles have been published on T-
cell unresponsiveness in BAL from smokers.37,38 The
reduced production of cytotoxic granule proteins
TIA-1 and granzyme-b, which are both involved in
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less predictable since another cytotoxic protein,
perforin, has been shown to be up regulated in
sputum CD8+ T-cells of smokers when compared to
non-smokers.42 If the effect of cigarette smoke
components on T-cell production of granzyme-b
and TIA-1 shown here reflect the in vivo situation,
T-cells exposed to cigarette smoke would be
impaired in their cytotoxic function, which could
lead to an inferior defence against airway infec-
tions. The decreased effector functions could
explain how the relatively high numbers of T-cells
that have been reported to be present in the lungs
of COPD patients and smokers11–13 can coincide
with frequent airway infections and reduced viral
clearance.1,4,8,9
On similar note, the ALI cultures of primary
human epithelial cells used in this study could
provide a relevant cell model of the tracheal
epithelium, and the up regulation of MUC5AC and
IL-8 production have been manifested in tissue and
sputum/lavage fluids respectively, in smokers and
COPD patients.10 Our data suggest that cigarette
smoke could be an important stimulus responsible
for these changes. In addition, chronic exposure to
cigarette smoke and the resulting changes in
quantity and composition of the mucus layer,
resulting in impaired mucociliary clearance of
pathogens and changes in the hydration state of
the mucus, could promote pathogen colonization in
the airway lumen.43
Taken together, this study shows that mechan-
isms, in both T-cells and epithelial cells, involved in
defence against infections can be altered by
cigarette smoke components. Since exacerbations
in COPD patients are often triggered by respiratory
infections,2,20 knowledge of how cigarette smoking
affects the likelihood of contracting and coping
with such infections is of great importance.Acknowledgements
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